BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10555450)

  • 1. The place of metabolic agents in the management of stable angina pectoris.
    Jackson G
    Rev Port Cardiol; 1999 Sep; 18 Suppl 4():IV23-7. PubMed ID: 10555450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical benefits of trimetazidine in patients with recurrent angina.
    Szwed H
    Coron Artery Dis; 2004 May; 15 Suppl 1():S17-21. PubMed ID: 15179124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current indications for percutaneous coronary intervention for chronic stable angina: implications of the COURAGE Trial.
    Kiernan TJ; Prasad A; Gersh BJ
    Rev Cardiovasc Med; 2007; 8(4):234-9. PubMed ID: 18192947
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal medical therapy is a proven option for chronic stable angina.
    O'Rourke RA
    J Am Coll Cardiol; 2008 Sep; 52(11):905-7. PubMed ID: 18772059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thirty years of coronary revascularization in stable angina pectoris. Results of randomized controlled trials].
    Høilund-Carlsen PF; Amtorp O
    Ugeskr Laeger; 2000 Jun; 162(24):3443-9. PubMed ID: 10918826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy in angina: a review of combined haemodynamic treatment and the role for combined haemodynamic and cardiac metabolic agents.
    Jackson G
    Int J Clin Pract; 2001 May; 55(4):256-61. PubMed ID: 11406911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
    Ruzyllo W; Szwed H; Sadowski Z; Elikowski W; Grzelak-Szafranska H; Orszulak W; Szymczak K; Winter M
    Curr Med Res Opin; 2004 Sep; 20(9):1447-54. PubMed ID: 15383193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
    Szucs TD; Schwenkglenks M; Rutishauser W
    Med Klin (Munich); 2000 Jan; 95(1):1-13. PubMed ID: 10668338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of chronic stable angina pectoris from a sceptic's view point.
    Kachru R; Kaul U
    J Indian Med Assoc; 2001 Jan; 99(1):45-7, 50-3. PubMed ID: 11480957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in patients with coronary artery disease after different treatments for angina in routine clinical practice.
    Benzer W; Höfer S; Oldridge NB
    Herz; 2003 Aug; 28(5):421-8. PubMed ID: 12928741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of stable angina pectoris.
    García-Palmieri MR
    Postgrad Med J; 1992; 68 Suppl 1():S61-4. PubMed ID: 1357641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranolazine (Ranexa) in the treatment of chronic stable angina.
    Aslam S; Gray D
    Adv Ther; 2010 Apr; 27(4):193-201. PubMed ID: 20449698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies.
    Szwed H; Hradec J; Préda I
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S25-8. PubMed ID: 11286304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment status of stable angina: medical treatment versus percutaneous coronary intervention versus coronary artery by-pass grafting.
    Battisti A; Tizzani E; Biondi-Zoccai G
    J Indian Med Assoc; 2009 Oct; 107(10):685-6, 691-4. PubMed ID: 20469742
    [No Abstract]   [Full Text] [Related]  

  • 17. Advantage of percutaneous coronary intervention over medical therapy in angina relief and the placebo effect.
    Rott D
    J Am Coll Cardiol; 2005 Jan; 45(2):327-8; author reply 328. PubMed ID: 15653043
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evidence-based optimal treatment strategy of patients with angina pectoris].
    Jánosi A
    Orv Hetil; 2008 Feb; 149(7):293-8. PubMed ID: 18258559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
    Szwed H; Sadowski Z; Elikowski W; Koronkiewicz A; Mamcarz A; Orszulak W; Skibińska E; Szymczak K; Swiatek J; Winter M
    Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS-II): prologue to COURAGE.
    King SB
    Circulation; 2007 Mar; 115(9):1064-6. PubMed ID: 17339563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.